Insider Trends: Charles River Labs International Insider Extends 90-Day Selling Trend
05:16 PM EDT, 05/10/2021 (MT Newswires) -- James C Foster, Director and Chairman, President & CEO, sold 7,500 shares in Charles River Labs International (CRL) for $2,573,770 on May 07, 2021. Foster, after the transactions outlined in the SEC Form 4 filing, controls 266,004 shares of company stock of which 216,072 shares are held directly and 49,932 shares are owned indirectly. The market value of the direct and indirect holdings, based on the prior-day closing price, is approximately $91.1 million.
During the most recent 90-day period, previous to the date of this filing, there have been 26 insider transactions reported to the SEC for Charles River Labs International. These transactions came from the activities of 8 separate insiders that resulted in a net disposition of 44,913 company shares. This compares with the preceding 90-day window of time where there were 17 transactions from 7 insiders and resulted in the net acquisition of 79,890 shares.
This level of insider transactions is lower than the peer group average in the 207-company Biotechnology & Medical Research peer group over the last 90-day period. Peer group activity averaged 65.9 transactions per company, with company insiders acquiring on average 45,201 shares.
SEC Story Link http://www.sec.gov/Archives/edgar/data/1100682/000112760221016094/xslF345X03/form4.xml
This report does not constitute a recommendation to purchase or sell any security and the analysts are not registered investment advisors. Further analysis is recommended before undertaking any position in any security. Any risks are solely the responsibility of the buyer/seller. The authors, publishers and distributors of the MT Newswires Live Briefs service and any associates thereof accept no liability for the content or actions taken by anyone or institution utilizing this report.